Search company, investor...
Abingdon Health company logo

Abingdon Health

Founded Year




Total Raised


Date of IPO


About Abingdon Health

Abingdon Health is commercializing Seralite‐ FLC Serum and Seralite– FLC Urine. These assays allow for the rapid quantitative measurement of kappa (K) and lambda (λ) immunoglobulin free light chains (FLCs) as an aid to the diagnosis and management of multiple myeloma.

Headquarters Location

National Innovation Campus Sand Hutton

York, England, YO41 1LZ,

United Kingdom

+44 (0) 121 414 5156

Missing: Abingdon Health's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Abingdon Health's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Abingdon Health

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Abingdon Health is included in 4 Expert Collections, including Medical Devices.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.



3,605 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.


Health Monitoring & Diagnostics

3,470 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Health IT

8,881 items

Latest Abingdon Health News

Unveiling the Potential of the Paper Diagnostics Market | Bio-Rad Laboratories, Siemens Healthcare, ARKRAY

May 22, 2023

| Bio-Rad Laboratories, Siemens Healthcare, ARKRAY News Provided By Share This Article Paper Diagnostics Market1 PORTLAND, OR, UNITED STATES, May 22, 2023 / / -- Paper Diagnostics Market - Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Paper Diagnostics Market. Some of the key players profiled in the study are ARKRAY, Acon Laboratories, Abbott, Bio-Rad Laboratories, Siemens Healthcare, Abcam, Abingdon Health, GVS, Kenosha Tapes, Micro Essential Laboratory, Navigene. Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures): Paper diagnostics, also known as paper-based diagnostic devices or paper-based assays, refer to a class of low-cost, portable, and disposable diagnostic tools that utilize paper as the primary material for analysis. These devices leverage the unique properties of paper, such as its capillary action, porosity, and ease of fabrication, to enable simple and rapid testing for various diseases and health conditions. Paper diagnostics have gained significant attention and popularity, particularly in resource-limited settings and remote areas, due to their affordability, ease of use, and ability to provide quick results without the need for complex laboratory infrastructure. The design of paper diagnostics typically involves the integration of various components, such as test zones, sample pads, and detection reagents, onto a paper substrate. These devices can be used for a wide range of diagnostic applications, including the detection of infectious diseases, such as malaria, HIV, and tuberculosis, as well as the monitoring of chronic conditions like diabetes. The simplicity and portability of paper diagnostics make them particularly valuable in settings with limited access to healthcare facilities or in emergency situations where rapid diagnosis is critical. Paper Diagnostics Market: Demand Analysis & Opportunity Outlook 2030 Paper Diagnostics research study defines market size of various segments & countries by historical years and forecast the values for next 7 years. The report is assembled to comprise qualitative and quantitative elements of Paper Diagnostics industry including: market share, market size (value and volume 2017-2021, and forecast to 2030) that admires each country concerned in the competitive marketplace. Further, the study also caters and provides in-depth statistics about the crucial elements of Paper Diagnostics which includes drivers & restraining factors that helps estimate future growth outlook of the market. Marketing Communication and Sales Channel Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable). Have Any Query? Ask Our Expert @: The segments and sub-section of Paper Diagnostics market is shown below: By Type: Diagnostic Devices, Monitoring Devices By Application: Clinical Diagnostics, Food Quality Testing, Environmental Monitoring, Others By Product: Lateral Flow Assays, Dipsticks, Paper-based Microfluidics, Others Some of the key players involved in the Market are: ARKRAY, Acon Laboratories, Abbott, Bio-Rad Laboratories, Siemens Healthcare, Abcam, Abingdon Health, GVS, Kenosha Tapes, Micro Essential Laboratory, Navigene. Important years considered in the Paper Diagnostics study: Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated] If opting for the Global version of Paper Diagnostics Market; then below country analysis would be included: – North America (USA, Canada and Mexico) – Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe) – Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC) – South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.) – Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA) Key Questions Answered with this Study: 1) What makes Paper Diagnostics Market feasible for long term investment? 2) How influencing factors driving the demand of Paper Diagnostics in next few years? 3) Territory that may see steep rise in CAGR & Y-O-Y growth? 4) What geographic region would have better demand for product/services? 5) What opportunity emerging territory would offer to established and new entrants in Paper Diagnostics market? 6) What strategies of big players help them acquire share in mature market? 7) Know value chain areas where players can create value? 8) What is the impact analysis of various factors in the Global Paper Diagnostics market growth? 9) Risk side analysis connected with service providers? Introduction about Paper Diagnostics Market Paper Diagnostics Market Size (Sales) Market Share by Type (Product Category) Paper Diagnostics Market by Application/End Users Paper Diagnostics Sales (Volume) and Market Share Comparison by Applications Global Paper Diagnostics Sales and Growth Rate (2020-2030) Paper Diagnostics Competition by Players/Suppliers, Region, Type, and Application Paper Diagnostics (Volume, Value, and Sales Price) table defined for each geographic region defined. Paper Diagnostics Players/Suppliers Profiles and Sales Data Key Raw Materials Analysis & Price Trends Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis ……..and view more in complete table of Contents Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @ Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia. Read More Articles: Smart Pills Market Update 2023–2030: Fertility Services Market Update 2023–2030: David Correa

Abingdon Health Frequently Asked Questions (FAQ)

  • When was Abingdon Health founded?

    Abingdon Health was founded in 2008.

  • Where is Abingdon Health's headquarters?

    Abingdon Health's headquarters is located at National Innovation Campus, York.

  • What is Abingdon Health's latest funding round?

    Abingdon Health's latest funding round is IPO.

  • How much did Abingdon Health raise?

    Abingdon Health raised a total of $13.97M.

  • Who are the investors of Abingdon Health?

    Investors of Abingdon Health include Northern Powerhouse Investment Fund, Mercia Asset Management, Touchstone Innovations, University of Birmingham and Chris Hand.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.